Sepsis and acute renal failure: Nephroprotection and continuous renal replacement therapy;Sepsis und akutes nierenversagen: Nephroprotektion und einsatz von nierenersatzverfahren

Intensivmedizin und Notfallmedizin

Volumn 43, Issue 3, 2006, Pages 175-188

  Kierdorf, H P ^a  

^a KLINIKUM BRAUNSCHWEIG   (Germany)

Author keywords

Acute renal failure; Continuous renal replacement therapy; Nephroprotection; Sepsis

Indexed keywords

ACETYLCYSTEINE; DOPAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; FUROSEMIDE; HYPERTENSIVE FACTOR; NORADRENALIN; OXYGEN RADICAL;

ACUTE KIDNEY FAILURE; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DIURESIS; FLUID RETENTION; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY PERFUSION; MORTALITY; MULTIPLE ORGAN FAILURE; PROGNOSIS; RENAL PROTECTION; RENAL REPLACEMENT THERAPY; REVIEW; SEPSIS; SEPTIC SHOCK; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VASOCONSTRICTION; VASODILATATION;

EID: 33645959176     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00390-006-0641-1     Document Type: Review

References (92)

1. Abassi ZA, Hoffman A, Better OS (1998) Acute renal failure complicating muscle crush injury. Semin Nephrol 18:558-565
2. Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, Sweet RM, Genter FC, Kurnik BR, Conger JD, Sayegh MH (1997) Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 336:828-834
3. Angstwurm MW, Schottdorf J, Schopohl J, Gaertner R (1999) Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med 27:1807-1813
4. Baue AE (1975) Multiple, progressive, or sequential systems failure. A syndrome of the 1970s. Arch Surg 110:779-781
5. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J (2000) Low-dose dopamine in patients with early renal dysfunction: a placebo- controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 356:2139-2143
6. Bellomo R, Tipping P, Boyce N (1993) Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 21:522-526
7. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A (1986) Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232:977-980
8. Billiau A, Vandekerckhove F (1991) Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur J Clin Invest 21:559-573
9. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J (2002) Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 30:2205-2211
10. Brezis M, Rosen S (1995) Hypoxia of the renal medulla-its implications for disease. N Engl J Med 332:647-655
11. Bullock ML, Umen AJ, Finkelstein M, Keane WF (1985) The assessment of risk factors in 462 patients with acute renal failure. Am J Kidney Dis 5:97-103
12. Bywaters EG (1990) 50 years on: the crush syndrome. BMJ 301:1412-1415
13. Cantarovich F, Rangoonwala B, Lorenz H, Verho M, Esnault VL (2004) High-Dose Flurosemide in Acute Renal Failure Study Group. High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Am J Kidney Dis 44:402-409
14. Chew SL, Lins RL, Daelemans R, De Broe ME (1993) Outcome in acute renal failure. Nephrol Dial Transplant 8:101-107
15. Clark WR, Müller BA, Alaka KJ, Macias WL (1994) A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. J Am Soc Nephrol 4:1413-1420
16. Clark WR, Müller BA, Kraus MA, Macias WL (1997) Extracorporeal therapy requirements for patients with acute renal failure. J Am Soc Nephrol 8:804-812
17. Cole L, Bellomo R, Hart G, Journois D, Davenport P, Tipping P, Ronco C (2002) A phase II randomized controlled trial of continuous hemofiltration in sepsis. Crit Care Med 18:235-240
18. Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P (2001) High-volume hemofiltration in human septic shock. Intensive Care Med 27:978-986
19. Conesa EL, Valero F, Nadal JC, Fenoy FJ, Lopez B, Arregui B, Salom MG (2001) N-acetyl-L-cysteine improves renal medullary hypoperfusion in acute renal failure. Am J Physiol Regul Integr Comp Physiol 281:730-737
20. Connors AF Jr, Speroff T, Dawson NV et al (1996) The effectiveness of right heart catheterization in the initial care of criticall ill patients. JAMA 276:889-897
21. Davenport A, Will EJ, Davidson AM (1993) Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 21:328-338
22. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM (2004) Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858-873
23. Denton MD, Chertow GM, Brady HR (1995) "Renal-dose" dopamine for the treatment of acute renal failure: scientific rationale, experimental studies and clinical trials. Kidney Int 49:4-14
24. Druml W, Lax F, Grimm G, Schneeweiss B, Lenz K, Laggner AN (1994) Acute renal failure in the elderly 1975-1990. Clin Nephrol 41:342-349
25. Elahi MM, Yann Lim M, Josph RN, Dhannapuneni RR, Spyt TJ (2004) Early hemofiltration improves survival in post-cardiotomy patients with acute renal failure. Eur J Cardiothorac Surg 26:1027-1031
26. Erley CM, Duda SH, Rehfuss D, Scholtes B, Bock J, Muller C, Osswald H, Risler T (1999) Prevention of radiocontrast-media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrol Dial Transplant 14:1146-1149
27. Faist E, Baue AE, Dittmer H, Heberer G (1983) Multiple organ failure in polytrauma patients. J Trauma 23:775-787
28. Fry DE, Pearlstein L, Fulton RL, Polk HC (1980) Multiple system organ failure. The role of uncontrolled infection. Arch Surg 115:136-140
29. Getting LG, Reynolds HN, Scalea T (1999) Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early versus late. Intensive Care Med 25:805-813
30. Goris RJ, te Boekhorst TP, Nuytinck JK, Gimbrere JS (1985) Multiple-organ failure. Generalized autodestructive inflammation? Arch Surg 120:1109-1115
31. Griffiths RD, Jones C, Palmer TE (1997) Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 13:295-302
32. Hack CE, Nuijens JH, Felt Bersma RJ, Schreuder WO, Eerenberg Belmer AJ, Paardekooper J, Bronsveld W, Thijs LG (1989) Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am J Med 86:20-26
33. Halpenny M, Rushe C, Breen P, Cunningham AJ, Boucher-Hayes D, Shorten GD (2002) The effects of fenoldopam on renal function in patients undergoing elective aortic surgery. Eur J Anaesthesiol 19:32-39
34. Hayes MA, Timmins AC, Yau EHS, Palazzo M,Hinds CJ, Watson D (1994) Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330:1712-1722
35. Heering P, Morgera S, Schmirz FJ, Schmitz G, Willers R, Schultheiss HP, Strauer BE, Grabensee B (1997) Cytokine removal and cardiovascular hemodynamics in septic patients with continuous hemofiltration. Intensive Care Med 23:288-296
36. Heidland A, Schaefer RM, Heidbreder E, Horl WH (1988) Catabolic factors in renal failure: therapeutic approaches. Nephrol Dial Transplant 3:8-16
37. Herbert MK, Ginzel S, Muhlschlegel S, Weis KH (1999) Concomitant treatment with urodilatin (ularitide) does not improve renal function in patients with acute renal failure after major abdominal surgery - a randomized controlled trial. Wien Klin Wochenschr 111:141-147
38. Holt S, Goodier D, Marley R, Patch D, Burroughs A, Fernando B, Harry D, Moore K (1999) Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. Lancet 353:294-295
39. Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, Hanique G, Matson JR (2000) Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 28:3581-3587
40. Huber W, Ilgmann K, Page M, Hennig M, Schweigart U, Jeschke B, Lutilsky L, Weiss W, Salmhofer H, Classen M (2002) Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study. Radiology 223:772-779
41. Huber W, Jeschke B, Page M, Weiss W, Salmhofer H, Schweigart U, Ilgmann K, Reichenberger J, Neu B, Classen M (2001) Reduced incidence of radiocontrast-induced nephropathy in ICU patients under theophylline prophylaxis: a prospective comparison to series of patients at similar risk. Intensive Care Med 27:1200-1209
42. Ix JH, McCulloch CE, Chertow GM (2004) Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis. Nephrol Dial Transplant 19:2747-753
43. Jaimes EA, del Castillo D, Rutherford MS, Raij L (2001) Countervailing influence of tumor necrosis factor-alpha and nitric oxide in endotoxemia. J Am Soc Nephrol 12:1204-1210
44. Joannidis M (2003) Pharmakologische Prävention des akuten Nierenversagens. Intensivmed 40:350-355
45. Kierdorf H (1991) Continuous versus intermittent treatment: Clinical results in acute renal failure. Contrib Nephrol 93:1-12
46. Kierdorf H (1994) Das akute Nierenversagen an der Schwelle zum 21. Jahrhundert. Nieren und Hochdruck 12:614-621
47. Kierdorf HP (2000) Aktuelle Aspekte der extrakorporalen Nierenersatzverfahren. Internist 41:1062-1070
48. Kierdorf HP, Seeliger S (1997) Acute renal failure in multiple organ dysfunction syndrome. Kidney Blood Press Res 20:164-166
49. Kierdorf HP, Sieberth HG (1995) Continuous treatment modalities in acute renal failure. Nephrol Dial Transplant 10:2001-2008
50. Kolff WJ (1947) New ways of treating uremia. Churchill Livingstone, London, New York
51. Kramer P, Wigger W, Rieger J, Matthaei D, Scheler F (1977) Arteriovenous haemofiltration: A new and simple method for treatment of over-hydrated patients resistant to diuretics. Klin Wochenschr 55:1121-122
52. Kshirsagar AV, Poole C, Mottl A, Shoham D, Franceschini N, Tudor G, Agrawal M, Denu-Ciocca C, Magnus Ohman E, Finn WF (2004) N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol 15:761-769
53. Landry DW, Oliver JA (2001) The pathogenesis of vasodilatatory shock. N Engl J Med 345:588-595
54. Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M (2000) Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 11:97-104
55. Lauer A, Alvis R, Avram M (1988) Hemodynamic consequences of continuous arteriovenous hemofiltration. Am J Kidney Dis 12:110-115
56. Lenz K, Hortnagl H, Druml W, Reither H, Schmid R, Schneeweiss B, Laggner A, Grimm G, Gerbes AL (1991) Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor. Gastroenterology 101:1060-1067
57. Leunissen KML, Hoorntje SJ, Fiers HA, Dekkers WT, Mulder AW (1986) Acetate versus bicarbonate haemodialysis in critically ill patients. Nephron 42:145-151
58. Levy EM, Viscoli CM, Horwitz RI (1996) The effect of acute renal failure on mortality - a cohort analysis. JAMA 275:1489-1494
59. Mehta RL (1996) Modalities of dialysis in acute renal failure. Seminars in Dialysis 9:469-475
60. Mehta RL, Pascual MT, Soroko S, Chertow GM (2002) Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 288:2547-2553
61. de Mendonca A, Vincent JL, Suter PM, Moreno R, Dearden NM, Antonelli M, Takala J, Sprung C, Cantraine F (2000) Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med 26:915-921
62. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA 3rd, Rittase RA, Norton HJ, Kennedy TP (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 19; 291:2328-2334
63. Metnitz PGH, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, Le Gall J-R, Druml W (2002) Effect of Acute Renal Failure Requiring Renal Replacement Therapy on Outcome in Critically Ill Patients. Crit Care Med 30:2051-2058
64. Morgera S, Rocktaschel J, Haase M, Lehmann C, von Heymann C, Ziemer S, Priem F, Hocher B, Gohl H (2003) Kox WJ, Buder HW, Neumayer HH. Intermittent high permeability hemofiltration in septic patients with acute renal failure. Intensive Care Med 29:1889-1995
65. Paganini EP, O'Hara P, Nakamoto S (1984) Slow continuous ultrafiltration in haemodialysis resistant oliguric acute renal failure patients. Trans Am Soc Artif Intern Organs 30:173-178
66. Paganini EP, Tapolyai M, Goormastic M, Halstenberg W, Kozlowski L, Leblanc M (1996) Establishing a dialysis therapy/Patients outcome link in ICU acute dialysis for patients with ARF. Am J Kid Dis 28:81-89
67. Parsons FM, Hobson SM, Blagg CR et al (1961) Optimum time for dialysis in acute reversible renal failure. Lancet I:129-134
68. Redl H, Schlag G (1992) Pathophysiologie des posttraumatischen Organversagens. Intensiv und Notfall 17:54-57
69. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 273:117-123
70. Redl-Wenzl EM, Armbruster C, Edelmann G, Fischl E, Kolacny M, Wechsler-Fordos A, Sporn P (1993) The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med 19:151-154
71. Rinaldo JE, Rogers RM (1986) Adult respiratory distress syndrome. N Engl J Med 315:578-580
72. Rivers E, Ngyuen B, Havstad S et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377
73. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G (2000) Effects of different doses in continuous venovenous hemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 355:26-30
74. Ronco C, Brendolan A, Dentini V, Ricci Z, Wratten ML, Bellomo R (2003) Coupled plasma filtration adsorption: rationale, technical development and early clinical experience. Blod Purif 21:409-416
75. Schiffl H, Lang SM, König A, Strasser T, Haider MC, Held E (1994) Biocompatible membranes in acute renal failure: prospective case controlled study. Lancet 344:570-572
76. Schrier WR, Wang W (2004) Acute renal failure and sepsis. N Engl J Med 351:159-169
77. Shilliday IR, Quinn KJ, Allison ME (1997) Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant 12:2592-2596
78. Sieberth HG, Freiberg J, Heinze J, Kostock G, Quiring FR, Schäfer E (1975) Der Einfluss nichtrenaler Organfunktionsstörungen auf die Überlebenschancen beim akuten Nierenversagen. Intensivmed 12:195-199
79. Sieberth HG (1993) Pathophysiology of acute kidney failure. Klin Anasthesiol Intensivther 45:3-12
80. Sieberth HG, Kierdorf HP (1999) Is cytokine removal by continuous hemofiltration feasable? Kidney Int 56:S79-S83
81. Sigler MH (1997) Transport characteristics of the slow therapies: Implications for achieving adequacy of dialysis in acute renal failure. Adv Ren Replace Ther 4:68-73
82. Springer TA (1990) Adhesion receptoss of the immune system. Nature 346:425-434
83. Solomon R, Werner C, Mann D, D'Elia J, Silva P (1994) Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331:1416-1420
84. Stevens PE, Riley B, Davies SP, Gower PE, Brown EA, Kox W (1988) Continuous arteriovenous haemodialysis in critically ill patients. Lancet II:150-152
85. Storck M, Hartl WH, Zimmerer E, Inthorn D (1991) Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure. Lancet 337:452-455
86. Tepel M, van Der GM, Schwarzfeld C, Laufer U, Liermann D, Zidek W (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180-184
87. Teschan PE, Baxter CR, O'Brien TF et al (1960) Prophylactic hemodialysis in the treatment of acute renal failure. Ann Intern Med 53:992-1016
88. Thadhani R, Pascual M, Bonventre JV (1996) Acute renal failure [see comments]. N Engl J Med 334:1448-1460
89. de Vries PMJM, Olthof CG, Solf A et al (1991) Fluid balance during hemodialysis and hemofiltration: The effect of dialysate sodium and a variable ultrafiltration rate. Nephrol Dial Transplant 6:257-263
90. Yurt RW, Lowry SF (1990) Role of the macrophage and endogenous mediators in multiple organ failure. In: Deitch EA (ed) Multiple organ failure. Thieme, Stuttgart New York, p 60-71
91. Wang A, Holcslaw T, Bashore TM, Freed MI, Miller D, Rudnick MR, Szerlip H, Thames MD, Davidson CJ, Shusterman N, Schwab SJ (2000) Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 57:1675-1680
92. Zilow G, Sturm JA, Rother U, Kirschfink M (1990) Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndrome. Clin Exp Immunol 79:151-157